Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New anti-HIV drug targeting HIV-1 envelope maturation presented by Pfizer

Feb. 20, 2006

Engineered component antigen enhances CTL responses for HIV vaccines

Feb. 20, 2006

Resistance profiling of a novel anti-V3 monoclonal antibody

Feb. 17, 2006

Novel Gb3 synthetic analogue demonstrates anti-HIV promise

Feb. 17, 2006

Recent Incyte patent describes new therapeutic agents for HIV infection

Feb. 16, 2006

Ranbaxy and CIH establish joint venture for antiretrovirals in South Africa

Feb. 16, 2006

TNX-355 targets HIV in a tropism-independent manner

Feb. 15, 2006

MK-0518 active, well tolerated in resistant HIV-1 infection

Feb. 15, 2006

DEBIO-025 well tolerated in HIV-1 infected subjects

Feb. 15, 2006

New selective nonpeptide CCR8 agonist presented

Feb. 14, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...